Mr. Binit Patel was honored with “International Best Researcher Award” at the International
Science and Technology Awards Congress 2025 (IISTAC 2025)
In March 2025, Binit Patel was bestowed with the “International Best Researcher Award” for
outstanding professional achievement in Research and Excellence in Pharmaceutical Science at
the International Science and Technology Awards Congress 2025 (IISTAC 2025).
Mr. Binit Patel is an esteemed researcher with over a decade of experience in renowned
pharmaceutical companies, including Hovione LLC and Aavis Pharmaceutical (USA), as well as
Zydus Lifescience Limited and Emcure Pharmaceuticals Limited (India). His research expertise
spans targeted cancer treatment, green excipients, and innovative drug delivery systems.
Notably, he had successfully developed and patented, Patent Registration 1: Federal Republic of
Germany, Certificate on the Registration of Utility Model No. 20 2024 102 831 for his liposomal
formulation of Hydroxyurea, which presents a stable, injectable formulation designed to
enhance drug bioavailability while minimizing systemic toxicity. Patent Registration 2: Federal
Republic of Germany, Certificate on the Registration of Utility Model No. 20 2024 103 209 for
his indole derivative-based formulation for targeted cancer treatment, which underscores his
innovative contributions to developing targeted therapies. Additionally, his research on
Moringa Gum as a natural disintegrant highlights the potential of green excipients to replace
synthetic alternatives, promoting sustainability in the pharmaceutical sector. His work on
comparative drug release study and stability indicating profile for drug product and self-
regulated crush-resistant drug delivery systems has paved the way for innovation in the
pharmaceutical industry. Additionally, his latest research on opioid abuse has also contributed
significantly to addressing this global health concern. Through his work, he had demonstrated a
commitment to advancing pharmaceutical research and improving human health. He holds
Master of Pharmacy Degree from RGPV University, India, and has collaborated with
international publishing houses, including Elsevier, Bentham Science, Wiley, and others
affiliated with Web of Science and Scopus. He had been authored over 20 research papers and
reviewed more than 30 manuscripts, showcasing my expertise and dedication to
pharmaceutical research. He has served as an Editorial Board Member for the Journal of
Medical and Pharmaceutical Sciences, further underscoring my reputation as a leading
researcher in pharmaceutical research field. He received the Fellowship of the Medical
Research Council (FMRC) from Global Journal, USA, for his creative methodologies in drug
discovery and research and development. This honor acknowledges his exceptional
contributions to the advancement of pharmaceutical research and its applications. In
conclusion, his research efforts have substantially advanced the pharmaceutical sector,
promoting the economic development of USA. His dedication to innovation, sustainability, and
enhancing human health has garnered him acclaim as a preeminent researcher in his domain.
